Takeda Stock Holds Firm amid New Drug Approvals and Global Market Shifts

Tokyo, Saturday, 29 August 2026.
Takeda Pharmaceutical maintains stable share performance on the Tokyo Stock Exchange, supported by recent U.S. and Japanese regulatory approvals, despite broader net losses and shifting global healthcare demand.